A detailed history of Ethic Inc. transactions in Laboratory Corp Of America Holdings stock. As of the latest transaction made, Ethic Inc. holds 1,419 shares of LH stock, worth $343,610. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,419
Holding current value
$343,610
% of portfolio
0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$199.35 - $236.0 $282,877 - $334,884
1,419 New
1,419 $317,000
Q1 2024

May 13, 2024

BUY
$209.01 - $232.56 $35,531 - $39,535
170 Added 13.61%
1,419 $309,000
Q4 2023

Feb 14, 2024

BUY
$197.69 - $227.29 $246,914 - $283,885
1,249 New
1,249 $283,000
Q2 2023

Aug 14, 2023

SELL
$211.93 - $241.33 $232,063 - $264,256
-1,095 Reduced 28.09%
2,803 $676,000
Q1 2023

May 12, 2023

SELL
$213.32 - $257.83 $181,108 - $218,897
-849 Reduced 17.88%
3,898 $894,000
Q4 2022

Feb 14, 2023

BUY
$203.72 - $248.97 $79,858 - $97,596
392 Added 9.0%
4,747 $1.12 Million
Q3 2022

Nov 14, 2022

BUY
$204.81 - $262.19 $74,960 - $95,961
366 Added 9.18%
4,355 $892,000
Q2 2022

Aug 10, 2022

BUY
$213.86 - $277.87 $293,415 - $381,237
1,372 Added 52.43%
3,989 $935,000
Q1 2022

May 16, 2022

BUY
$259.82 - $298.18 $491,059 - $563,560
1,890 Added 259.97%
2,617 $690,000
Q4 2021

Feb 14, 2022

SELL
$271.6 - $314.21 $122,491 - $141,708
-451 Reduced 38.29%
727 $228,000
Q3 2021

Nov 15, 2021

BUY
$274.82 - $308.34 $108,279 - $121,485
394 Added 50.26%
1,178 $332,000
Q2 2021

Aug 10, 2021

SELL
$251.87 - $278.14 $114,600 - $126,553
-455 Reduced 36.72%
784 $216,000
Q1 2021

May 13, 2021

BUY
$204.88 - $255.03 $253,846 - $315,982
1,239 New
1,239 $316,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $21.7B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Ethic Inc. Portfolio

Follow Ethic Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ethic Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ethic Inc. with notifications on news.